Announcement on behalf of Obigen’s resolution to lift the non-competition restrictions for directors at 2023 annual shareholders’ meeting

1.Date of the shareholders’ meeting resolution:2023/06/16 2.Name and title of the managerial officer with permission to engage in competitive conduct: Director Frank Chen, Representative of OBI Pharma, Inc. Director Chung Yao Yin, Representative of RuentexSin, inc. Director Yun Yen, Representative of OBI Pharma, Inc. Director Jo Ma, Representative of OBI Pharma, Inc. Director Hsing-Ming Chen, […]